Received Feb 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Skin reaction; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of skin reaction in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced skin reaction (Verbatim: Skin reaction). The outcome of the skin reaction was not reported. It was unknown if the reporter considered the skin reaction to be related to Shingrix. It was unknown if the company considered the skin reaction to be related to Shingrix. Additional Information: GSK Receipt Date: 10-FEB-2025 The patient self reported this case for himself/herself This case was reported by a patient via (Shingrix GSK Chatbot) interactive digital media.